Reforming the Orphan Drug Act for the 21st Century

N Engl J Med. 2019 Jul 11;381(2):106-108. doi: 10.1056/NEJMp1902943.
No abstract available

MeSH terms

  • Drug Costs
  • Drug Development / economics
  • Drug Development / legislation & jurisprudence*
  • Drug Industry / economics*
  • Drug Industry / legislation & jurisprudence
  • Drugs, Generic
  • Health Care Reform
  • Humans
  • Orphan Drug Production / legislation & jurisprudence*
  • Patents as Topic / legislation & jurisprudence
  • Rare Diseases / drug therapy
  • Rare Diseases / economics
  • Research Support as Topic / economics
  • Research Support as Topic / legislation & jurisprudence
  • United States

Substances

  • Drugs, Generic